IFNA1 and systemic lupus erythematosus: Although there are limited studies investigating whether vitamin D affects pathogenic mechanisms in SLE, based on the available evidence in vitro that vitamin D is able to prevent dendritic cell maturation, inhibit IFN-α production, alter B cell phenotype and potentially reduce the IFN signature response it is likely to have a significant impact on the dysregulated immune response.